GH1 and prostate carcinoma: Additionally, increased GHR expression and autocrine/paracrine GH secretion in the tumor microenvironment (TME) have been reported in several different types of cancers, including colon, breast, pancreatic, gastric, and prostate cancers [28,29,30,31,32,33].